20 May 2026
When to best combine guided-directed medical therapy and devices at discharge of acute heart failure
With the collaboration of the iHF initiative (improving Heart Function)
Anchorperson:
A. Mebazaa
Spokesperson:
P. Vranckx
Summary
This session addresses the challenges and strategies in optimizing guided-directed medical therapy for acute heart failure patients, especially those intolerant to up-titration. It also covers the assessment and timing for cardiac resynchronisation therapy (CRT), highlighting the benefits of combining medical therapy and device implantation to improve patient outcomes.
Learning Objectives
- To learn about the benefits and limits of optimisation of guided-directed medical therapy for heart failure
- To undestand when and how to assess the need for cardiac resynchronisation therapy
- To understand benefits of combining guided-directed medical therapy and cardiac resynchronisation therapy when needed